COMPARISON OF LONG-TERM RESULTS OF FEMORAL VEIN LIGATION AND TRANSCATHETER THROMBOLYSIS IN THROMBOSIS OF THE FEMORAL SEGMENT

INTRODUCTION. The problem of preventing massive pulmonary thromboembolism and post-thrombotic syndrome in deep vein thrombosis has been studied for a long period. The introduction of new treatments for deep vein thrombosis requires a detailed comparison of their effectiveness.

The OBJECTIVE of this work was a comparative analysis of ligation of the superficial femoral vein and regional thrombolytic therapy.

MATERIAL AND METHODS. A retrospective multicenter study involving 30 patients with femoproplite thrombosis, who had received catheter-directed thrombolysis or ligation of the superficial femoral vein, was performed. The investigated patients underwent inpatient treatment.

RESULTS. The data on the effectiveness of both methods in preventing pulmonary thromboembolism were obtained. When comparing both groups, we revealed a statistically significant difference in the frequency of the development of PTS and the severity of its development in 1 year after treatment. With ligation vein, 73.3 and 6.7% in the thrombolysis group (p=0.0005).

CONCLUSION. Regional thrombolysis was an effective treatment for deep vein thrombosis and prevention of PTS.

The authors declare no conflict of interest.

The authors confirm that they respect the rights of the people participated in the study, including obtaining informed consent when it is necessary, and the rules of treatment of animals when they are used in the study. Author Guidelines contains the detailed information.

1. Homans J. Thrombosis of the deep veins of the lower leg, causing pulmonary embolism. New England J. of Medicine. 1934;211(22): 993–997.

2. Pokrovskij A. V. Rossijskie klinicheskie rekomendacii po diagnostike, lecheniyu i profilaktike venozny`x tromboe`mbolicheskix oslozhnenij. Flebologiya. 2010;2:34–44. (In Russ.).

3. La Scienya M. J. et al. Catheter-directed thrombolysis and/or thrombectomy with selective endovascular stenting as alternatives to systemic anticoagulation for treatment of acute deep vein thrombosis. The American J. of surgery. 2005;190(6):871–876.

4. Kahn S. R., Ginsberg J. S. The post-thrombotic syndrome: current knowledge, controversies, and directions for future research. Blood reviews. 2002;16(3):155–165.

5. Cohen A. T. et al. Venous thromboembolism (VTE) in Europe. Thrombosis and haemostasis. 2007;98(4):756–764.

6. Prozorov S. A. Oslozhneniya, nablyudaemy`e vo vremya implantacii kava-fil`trov i v razny`e sroki posle nee. Pokazaniya k udaleniyu kavafil`trov. Obzor literatury`. Mezhdunarodny`j zhurnal intervencionnoj kardioangiologii. 2016;(45).

7. Kahn S. R. et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Annals of internal medicine. 2008;149(10):698–707.

8. Rossiyskiye klinicheskiye rekomendatsii po diagnostike, lecheniyu i profilaktike venoznykh tromboembolicheskikh oslozhneniy. Flebologiya. 2010;(1):2–37.

9. Byrne J. J. Phlebitis: a study of 748 cases at the Boston City Hospital. New England J. of Medicine. 1955;253(14):579–586.

10. Kearon C. et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–352.

11. Goktay A. Y., Senturk C. Endovascular treatment of thrombosis and embolism. Thrombosis and Embolism: from Research to Clinical Practice. Cham, Springer. 2016:195–213.

12. Vedantham S. Interventional Therapy for Prevention of Post-Thrombotic Syndrome-Results of the NHLBI-Sponsored ATTRACT Trial. Presentation at the Forty-second Annual Scientific Meeting of the Society of Interventional Radiology. 2017:4–9.

13. Marston W. A. Results of the ATTRACT trial do not change the management of acute deep vein thrombosis. J. of Vascular Surgery: Venous and Lymphatic Disorders. 2018;6(1):5–6.

14. Mewissen M. W. et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211(1):39–49.

15. Baekgaard N. Benefit of catheter-directed thrombolysis for acute iliofemoral DVT: myth or reality? European J. of Vascular and Endovascular Surgery. 2014;48(4):361–362.

16. Lin P. H., Ochoa L. N., Duffy P. Catheter-directed thrombectomy and thrombolysis for symptomatic lower-extremity deep vein thrombosis: review of current interventional treatment strategies. Perspectives in vascular surgery and endovascular therapy. 2010;22(3):152–163.

17. Hirsh J. et al. Antithrombotic and thrombolytic therapy: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2008;133(6):110S–112S.

18. Kearon C. et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–352.

19. Kearon C. et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012; 141(2):e419S–e496S.

20. Büller H. R. et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3):401S–428S.

21. Meissner M. H. Thrombolytic therapy for acute deep vein thrombosis and the venous registry. Reviews in cardiovascular medicine. 2002;3:S53–60.

22. Comerota A. J., Paolini D. Treatment of acute iliofemoral deep venous thrombosis: a strategy of thrombus removal. European J. of vascular and endovascular surgery. 2007;33(3):351–360.

23. Vedantham S. et al. Lower extremity venous thrombolysis with adjunctive mechanical thrombectomy. J. of Vascular and Interventional Radiology. 2002;13(10):1001–1008.

24. Amin V. B., Lookstein R. A. Catheter-directed interventions for acute iliocaval deep vein thrombosis. Techniques in vascular and interventional radiology. 2014;17(2):96–102.

25. Watson L., Broderick C., Armon M. P. Thrombolysis for acute deep vein thrombosis. Cochrane Database of Systematic Reviews. 2014;(1).

26. Enden T. et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. The Lancet. 2012;379(9810):31–38.

27. Enden T. et al. Catheter‐directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short‐term patency. J. of thrombosis and haemostasis. 2009;7(8):1268–1275.

28. Srinivas B. C. et al. Catheter-directed thrombolysis along with mechanical thromboaspiration versus anticoagulation alone in the management of lower limb deep venous thrombosis – a comparative study. The International J. of angiology. 2014;23(4):247.

29. Watson L., Broderick C., Armon M. P. Thrombolysis for acute deep vein thrombosis. Cochrane Database of Systematic Reviews. 2016. Doi: http://dx.doi.org/10.1002/14651858.cd002783.pub4.

30. Broholm R., Panduro L. J., Bækgaard N. Catheter-directed thrombolysis in the treatment of iliofemoral venous thrombosis. A review. International angiology. 2010;29(4):292–302.

31. Kim H. S. et al. Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: clinical and economic outcomes. J. of vascular and interventional radiology. 2006;17(7):1099– 1104.

32. Haig Y., Enden T., Grøtta O., Kløw N. E., Slagsvold C. E., Ghanima W., Njaaastad A. M. et al. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. The Lancet Haematology. 2016;3(2):e64–e71.